Guardian Pharmacy Services, Inc. (NYSE: GRDN) is a Healthcare company (Medical - Care Facilities) with a market capitalization of $3.2B. The Maz Rating grades it against the other companies in its sector.
Guardian Pharmacy Services, Inc.'s current Maz Rating and its five factor grades are for members: log in to see them.
At $50.33, Guardian Pharmacy Services, Inc. trades at 42.5x trailing earnings, 2.2x sales and 11.9x book value, with an EV/EBITDA of 23.9. Over the last twelve months it generated about $1.5B of revenue and $75M of net income. It runs a gross margin of 22.4%, an operating margin of 6.9% and a net margin of 5.1%. It shows return on equity of 31.8%, return on invested capital of 22.6% and a free cash flow yield of 3.0%. On the balance sheet: a debt-to-equity ratio of 0.13 and a current ratio of 1.65. Over the past 52 weeks the share price ranged from $26.34 to $50.80, with a beta of 0.10.
Guardian Pharmacy Services, Inc. does not currently pay a dividend.
4 Wall Street analyst ratings cover the stock: 4 Buy, for a Buy consensus. This is the sell side's view, separate from the Maz Rating.
Guardian Pharmacy Services, Inc. operates as a pharmaceutical service provider, delivering an extensive array of tech-driven solutions. These services are specifically crafted to enhance the care of residents within long-term health care facilities (LTCFs) across the United States. The company specializes in offering personalized clinical assistance, efficient drug distribution, and comprehensive administrative support. These provisions are particularly beneficial for individuals in less acute long-term care environments, such as assisted living communities, behavioral health centers, and group homes. To bolster its operations, the company offers Guardian Compass, a platform that generates insightful dashboards from its extensive data warehouse. This tool enables its network of local pharmacies to effectively strategize, monitor performance, and refine their business processes. Furthermore, Guardian Pharmacy Services develops dedicated GuardianShield Programs for LTCFs. The company was established in 2003 and is based in Atlanta, Georgia.
Figures are trailing twelve months unless stated. The Maz Rating and Maz Dividend Score rank a company against its own sector; they are not price targets or recommendations.
It depends on the standard you follow. As of September 2026, Guardian Pharmacy Services, Inc. (GRDN) passes 4 of 5 published Shariah screening standards checked by Maz Vantage: it passes AAOIFI, S&P Global, Dow Jones and MSCI, and fails FTSE.
| Standard | Ratios (value / limit) | Result |
|---|---|---|
| AAOIFI | Debt / Mkt Cap (36m) 0.00% / 30% · (Cash+Inv) / Mkt Cap (36m) 4.53% / 30% · Interest income / Revenue 0.00% / 5% | Pass |
| S&P Global | Debt / Mkt Cap (36m) 0.00% / 33% · (Cash+ST Inv) / Mkt Cap (36m) 4.53% / 33% · Receivables / Mkt Cap (36m) 4.07% / 49% · Interest income / Revenue 0.00% / 5% | Pass |
| Dow Jones | Debt / Mkt Cap (24m) 0.00% / 33.33% · (Cash+ST Inv) / Mkt Cap (24m) 4.53% / 33.33% · Receivables / Mkt Cap (24m) 4.07% / 33.33% · Interest income / Revenue 0.00% / 5% | Pass |
| MSCI | Debt / Avg Assets (4Q) 0.42% / 33.33% · (Cash+ST Inv) / Avg Assets (4Q) 19.2% / 33.33% · Receivables / Avg Assets (4Q) 23.9% / 33.33% · Interest income / Revenue 0.00% / 5% | Pass |
| FTSE | Debt / Total Assets 0.00% / 33.33% · (Cash+ST Inv) / Total Assets 24.3% / 33.33% · (Cash+Recv) / Total Assets 46.2% / 33.33% · Interest income / Revenue 0.00% / 5% | Fail |
It depends on the standard you follow. As of September 2026, Guardian Pharmacy Services, Inc. (GRDN) passes 4 of 5 published Shariah screening standards checked by Maz Vantage: it passes AAOIFI, S&P Global, Dow Jones and MSCI, and fails FTSE.
Yes. Guardian Pharmacy Services, Inc. is within every AAOIFI limit: debt and interest-bearing cash and investments under 30% of its 36-month average market cap, and interest income under 5% of revenue.
Guardian Pharmacy Services, Inc. reported no interest income in the latest quarter, so there is nothing to purify from its dividend on that basis.
The screen is rerun on each quarterly report; the figures here are from the balance sheet dated September 30, 2026 (Q3 2026). A status can change from one quarter to the next as debt, cash and market value move.
See also the list of halal stocks, halal healthcare stocks, the halal stock screener, the dividend purification calculator and the zakat calculator.
A mechanical screen of published financial ratios and the company's line of business, not a religious ruling. It does not test every revenue stream; check with a scholar you trust.